Institutions / General Atlantic, L.P.
General Atlantic, L.P.
CIK 1017645 · Institutionalso an insider · as of Mar 31, 2026
Portfolio value
$2.15B
Positions
12
As of
Mar 31, 2026
Portfolio trend
Portfolio value
$2.15B-25.2%Positions
12-7.7%Top holdings
Mar 31, 2026
| Company | Value | % of portfolio |
|---|---|---|
| Dlocal | $605.14M | 28.2% |
| Chime Financial, Inc. | $398.19M | 18.5% |
| Xp, Inc | $391.58M | 18.2% |
| Alkami Technology, Inc. | $240.34M | 11.2% |
| Pharvaris N.V. | $226.88M | 10.6% |
| European Wax Center, Inc. | $75.78M | 3.5% |
| Revolution Medicines, Inc. | $68.83M | 3.2% |
| Nurix Therapeutics, Inc. | $63.58M | 3.0% |
| Centessa Pharmaceuticals | $53.81M | 2.5% |
| Riskified Ltd. | $20.87M | 1.0% |
| Grove Collaborative Holdings, Inc.GROV | $3.17M | 0.1% |
| Webull | $243.9K | 0.0% |
Activity
Mar 31, 2026View full history →
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Q1 2026 as of | Exit | Alignment Healthcare, Inc. | $-260.06M | -13.2M -100.00% | — | high |
| Q1 2026 as of | Trim | Revolution Medicines, Inc. | $-204.72M | -2.1M -74.84% | 707,791 3.20% of portfolio | high |
| Q1 2026 as of | Trim | 152309100 | $-189.18M | -4.8M -77.85% | 1,354,830 2.50% of portfolio | high |
| Q1 2026 as of | Add | Alkami Technology, Inc. | $52.43M | +3.3M +27.90% | 15,337,495 11.19% of portfolio | high |
| Q1 2026 as of | Trim | G98239109 | $-40.61M | -2.1M -9.40% | 20,566,133 18.23% of portfolio | medium |
| Q1 2026 as of | Trim | Nurix Therapeutics, Inc. | $-12.33M | -795K -16.24% | 4,101,865 2.96% of portfolio | medium |
Insider transactions
Also files Forms 3 / 4 / 5
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Mar 10, 2026 | Buy | ALKT Alkami Technology, Inc. Common Stock | $19.38M | +1.1M +8.57% | 13,979,451 13.07% of shares | high |
| Mar 11, 2026 | Buy | ALKT Alkami Technology, Inc. Common Stock | $16.57M | +900K +6.44% | 14,879,451 13.91% of shares | high |
| Mar 9, 2026 | Buy | ALKT Alkami Technology, Inc. Common Stock, par value $0.001 per share ("Common Stock") | $14.61M | +842K +7.00% | 12,875,702 12.04% of shares | high |
| May 6, 2026 | Buy | ALKT Alkami Technology, Inc. Common Stock | $14.05M | +845K +5.09% | 17,445,994 16.31% of shares | high |
| May 12, 2026 | Buy | ALKT Alkami Technology, Inc. Common Stock, par value $0.001 per share ("Common Stock") | $12.65M | +750K +4.30% | 18,195,994 17.01% of shares | high |
| May 5, 2026 | Buy | ALKT Alkami Technology, Inc. Common Stock | $11.79M | +700K +4.40% | 16,601,222 15.52% of shares | high |
| May 14, 2026 | Buy | ALKT Alkami Technology, Inc. Common Stock | $11.13M | +675K +3.60% | 19,420,994 18.16% of shares | high |
| Mar 12, 2026 | Buy | ALKT Alkami Technology, Inc. Common Stock, par value $0.001 per share ("Common Stock") | $9.16M | +500K +3.36% | 15,379,451 14.38% of shares | high |
| May 13, 2026 | Buy | ALKT Alkami Technology, Inc. Common Stock | $9.15M | +550K +3.02% | 18,745,994 17.53% of shares | high |
| May 4, 2026 | Buy | ALKT Alkami Technology, Inc. Common Stock, par value $0.001 per share ("Common Stock") | $8.83M | +522K +3.39% | 15,901,222 14.87% of shares | high |